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Abstract 
This report details the results of an ongoing project to engineer a mutant form of Red Fluorescent 
Protein (RFP) variant mCherry that acts as a real-time in vivo protease sensor. The sought-after 
mutant only becomes fluorescent when exposed to Tobacco Etch Virus (TEV) Protease, this 
system’s model protease. This will be accomplished via the insertion of the TEV Protease 
Recognition Site (TEV-PRS) in such a position that, before cleavage, will prevent the protein 
from folding to fluorescent conformation, but upon cleavage, will allow for fluorescent 
conformation to occur. The cylindrical structure of the protein, composed of beta-pleated sheets, 
contains “loops” connecting these sheets, was analyzed, and sixteen sites were identified within 
these loops as candidates for insertion sites of the TEV-PRS. Using Site-Directed Mutagenesis 
(SDM) and Overlap-Extension Polymerase Chain-Reaction (OE-PCR), insertion at twelve of the 
identified sites has been attempted, two of which have been expressed in surface display yeast, 
digitally imaged, and their initial (pre-cleavage) fluorescence has been quantified. Four of the 
intended sites were successfully mutated, in addition to one accidental site. While the sought 
after mutant has not yet been identified, the results at this stage indicate promise, and further 
study is recommended and will be carried on in the future by other Research Assistants. 
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Introduction and Theory  
Sensing protein activity in vivo is a great challenge. While protein assays can be performed upon 
the spilled contents of lysed cells to find concentrations, this requires that the cells die. These 
assays, as a result, only roughly reveal the protein concentration at the time of lysis, not over 
time. In the case of prokaryotes or single-celled eukaryotes, groups of cells can be carried 
through the same conditions and made to lyse at different times, generating a profile of 
concentration over time. This process, however, is cumbersome, and introduces a possible source 
of error in the presence of a lytic agent; it may cause degradation or misfolding of the proteins of 
interest. Additionally, in the case of multicellular eukaryotes such as animals, this strategy 
becomes increasingly difficult to implement due to the complex nature of the organisms. 
Therefore, a non-invasive method of detecting protein activity in real time would be a highly 
useful tool for investigation of gene expression and protein function, especially in plants and 
animals. Perhaps the most significant advantage, however, would be the ability to detect protein 
activity in living organisms, either unicellular or multicellular. One such signaling method would 
be fluorescence. Light, unlike other signaling agents, can travel harmlessly through cells and can 
be easily detected, and even quantified, by photovoltaic sensors. 
 
One particular example of a use for these sorts of sensors would be in detecting the real-time 
activity of certain proteases in Drosophila melogaster, a common fruit fly. This multicellular 
organism is of great interest in the study of multicellular genetics, as, similar to Escherichia coli 
among bacteria, Drosophila has been studied in great detail relative to other animals, and the 
understanding of its gene expression is relatively deep. One major gap in understanding, 
however, is the genetic and physiological mechanism behind ovulation [1]. Certain proteases are 
speculated to be involved [2]. The ability to sense the presence of these proteins in real time 
could potentially elucidate their role in the ovulation process, shedding great light on the species, 
and multicellular organisms in general [3]. Due to the suspected involvement of a protease in 
Drosophila ovulation, this mystery could be a prime candidate for the application of a 
fluorescent protease sensor system in vivo. 
 
 
Figure 1; Visualization of the mCherry secondary and tertiary structure generated in PyMOL with an Educational License, with 
the color gradient from N to C terminus. 
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In designing such a system, the fluorescent molecule selected should be optimized for the 
application; in this case, fluorescence must be detectible from within the organism. A few 
varieties of fluorescent proteins occur in nature. The most well-known is likely Green 
Fluorescent Protein (GFP), derived from jellyfish. The protein is made up of a “barrel” shape 
constructed from beta-pleated sheets, as well as a fluorescent core made up of several alpha 
helices. Another variety is known as dsRed, derived from coral-reef organisms [4]. While similar 
in structure, the wavelengths of light emitted are at the lower-frequency end of the visible 
spectrum. This is ideal for in vivo detection within organisms, as longer wavelengths of light can 
more effectively pass through tissue. This heterodimeric protein has been mutated, [4] generating 
variants with different fluorescent wavelengths, one of which is a monomer called mCherry. 
mCherry is a monomeric protein capable of emitting peak fluorescence at a wavelength of 610 
nm [5]. Due its exceptionally high photostability and maturation rate, and low bleaching rate,  is 
an excellent candidate for use as a signaling agent. [6]  
 
An important factor for use as a signaling agent is that the mechanism of initiating signaling 
should not be transcriptional. The reason for this is that, were this the case, sensing would 
depend upon gene expression, which is very difficult to predict in multicellular eukaryotes. 
Additionally, a very high concentration of the protein being monitored would need to accumulate 
in order for detection to be possible, meaning that if the protein is only active at very low 
concentrations, the fluorescence would not be sufficient. A more significant issue with 
expressional signaling is that expression can take hours to occur at a level sufficient for 
detection. This time delay makes real time detection impossible. 
 
As an alternative, the mCherry protein will be engineered into a protease sensor. The goal of this 
project will be to create a protein which is naturally non-fluorescent, but becomes fluorescent in 
the presence of a protease via recognition-site-cleavage. This will be accomplished by inserting 
DNA coding for recognition site for the Tobacco Etch Virus Protease, or TEV Protease at 
various spots or “Insertion Sites”. Criteria for the site are as follows: 
• Must be between codons, such that all codons in the mCherry gene and TEV Protease 
Recognition Site (TEV-PRS) remain intact and no frameshift mutations occur. 
• Must not disturb the secondary structure of the mCherry protein, by breaking up any 
beta-sheets or alpha-helices, as this would irreparably damage the structure.  
• Must be present on the surface of the roughly cylindrical protein structure, such that the 
protease will be able to access the recognition site. 
mCherry is also optimal for TEV-PRS insertion for the reason that it is a monomeric protein, so 
impacting oligomerization behavior with insertions is not a concern. 
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Figure 2; Visual map of mCherry structure wherein arrows represent 𝛽-pleated sheets and cylinders represent 𝛼-helices. 
As a result of these restrictions, the sites will be present in the loops which connect the beta-
sheets with each other and also the fluorescent core at the top and bottom of the protein. The 
behavior of the protein and the function of the inserted recognition site will be as follows: the 
inserted sequence will initially cause the protein to be unable to fold into a fluorescent 
conformation by “blocking” this formation. The presence of TEV, even at low concentrations, 
will lead to virtually instantaneous cleavage of these sites, allowing the proteins to come together 
and fluoresce, without otherwise impacting the behavior or metabolism of the cell. 
Methods and Materials 
Various kits, enzymes, cells, DNA and plasmids, and lab equipment were employed throughout 
the lab work that went into this thesis.  
Enzymes 
Phusion High-Fidelity DNA polymerase from Thermo-Scientific was used for all PCR reactions, 
and performed all in vitro DNA amplification in-lab. Similarly to Taq polymerase, Phusion 
operates optimally at high temperatures (72°C), but has 52x fidelity. 
 
T4 DNA Ligase was used for ligation reactions to “repair nicks” in DNA; in other words, the 
ligase catalyzes the formation of phosphodiester bonds to join adjacent nucleotides (connected 
by complementary “sticky ends at restriction sites, for example). 
 
DpnI [7] is a restriction enzyme which is used for digesting methylated DNA. Methylation, being 
a tool used for in vivo gene expression, would only be present in DNA produced in vivo, but not 
synthetic DNA produced via PCR. 
 
The High-Fidelity versions of NheI and BsrGI restriction enzymes were used to cleave an insert 
containing the yo-mCherry gene from plasmids. 
 
   
 
Figure 3; Cleavage sites for BsrGI-HF (left) and NheI-HF (right) from New England Bio Labs 
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Cells 
The bacterial cells used in plasmid amplification were TOP10 strain E. coli cells from 
Invitrogen.  These cells were selected for their high transformation efficiency (1x109 CFU/g 
plasmid) and chemical competence, which make them ideal for high efficiency cloning and 
plasmid propagation. Chemical competence is achieved by treating the cells with calcium 
chloride to facilitate plasmid DNA attachment to the cell membrane, increasing transformation 
efficiency. The cells lack antibiotic resistance, and allow for stable replication of plasmids with 
high copy number. 
The yeast cells used in fluorescence expression tests for the mutated mCherry genes were 
EBY100 strain Saccharomyces cerevisiae, a strain of yeast optimized for surface display. The 
strain contains the GAL operon, and also an insertion of AGA1 regulated by GAL. AGA1 codes 
for the anchorage subunit of a-agglutinin, which embeds in the cell wall of molecules, and allows 
for the surface presentation of AGA2 linked . This means that in the presence of galactose as a 
carbon source, AGA1 and other GAL-linked genes are expressed. 
DNA/Genetic Data 
The gene coding for the protein of interest, mCherry, was a preexisting yeast-optimized variant. 
While the resulting amino-acid sequence is the same, the codons are optimized based upon the 
codon tRNA bias within the yeast genome. 
 
The two plasmids employed in this research project were pN3 [8] and pCT302 [9]. 
 
Figure 4; Plasmid maps of pCT302 (left) and pN3 (right) from addgene 
pCT302 is a yeast expression plasmid which is just over 6.1 kb in size without the insertion. It 
contains the gene for Ampicillin resistance, as well as that for yeast Tryptophan synthase. 
pCT302 also contains a GAL promoter and AGA2 linked to the insertion site, so when 
transformed into EBY100 yeast and induced by presence of galactose, the insert-aga2 complex 
disulfide bonds to the aga1 complex on the yeast surface and can be detected outside the cell. 
 
pN3 is a mammalian expression plasmid just under 4kb in size without an insert. It contains the 
gene for Kanamycin resistance. 
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Mutation 
Two methods, Site Directed Mutagenesis (SDM), and Overlap Extension Polymerase-Chain 
Reaction (OE-PCR) were employed to perform the insertion mutation. Both methods used the 
same plasmids, and had the same end result, but each had different requirements and procedures. 
Site Directed Mutagenesis (SDM) 
The first of two mutagenesis techniques employed was Site-Directed Mutagenesis (SDM). The 
technique requires 2 complementary oligonucleotides to act as primers. Starting from the 5’ end, 
the oligonucleotides must include roughly 20 base pairs upstream of the insertion point, followed 
by the insertion sequence, followed by roughly 20 base pairs downstream. The reaction solution 
is prepared to contain 10 pmol of each oligonucleotide primer, 50 ng template plasmid, 10 𝜇L 
5X reaction buffer (containing various buffers, BSA, and detergent to ensure proper polymerase 
function), 1 𝜇L dNTP to fuel synthesis of DNA, and 0.5 𝜇L Phusion DNA polymerase, made up 
to a volume of 50𝜇𝐿 with ddH2O. It is important to keep the solution and all components on ice 
up until it is placed into the thermal cycler to prevent denaturation of the polymerase.  
The thermal cycle, as depicted in Figure 5B, begins with 1 minute of denaturation phase at 95°C 
before beginning the 280 second cycle of denaturation-annealing-extension. The denaturation 
phase is also run at 95°C so that all dsDNA separates to allow primers to bond during the 
annealing phase. The 50 second annealing phase is run at 65°C, allowing primers to bond to the 
template plasmids (as shown in the first phase of Figure 5A). The 180 second extension phase is 
run at 72°C, and at this point the Phusion DNA polymerase attaches to the primers which are 
bonded to the template plasmid and extends the plasmids in the 3’ direction around the circular 
plasmid until it encounters the 5’ end of the plasmid being extended, where it detaches. The 
extension phase for this SDM cycle is longer than that for a standard PCR cycle. This is because 
the polymerase must extend the primer around the entire template plasmid, more than 4kb. The 
SDM reaction cycles 18 times, and does not propagate exponentially in the way that PCR does. 
At the conclusion of the 18th cycle, 5 additional minutes are allowed for extension, and then the 
products are held indefinitely at 4°C, where they can be safely stored for 1-2 days. 
  
Figure 5; A; Visual representation of Site-Directed Mutagenesis used for 
insertion, derived from Geiser et al. [10]. The segmented loop represents the 
template plasmid (which is methylated, as it was synthesized in vivo), while 
the thick black segment represents the insertion. The primers are extended 
from the 3’ end along the template DNA until termination at their own 5’ end, 
resulting in a complete, nicked plasmid with the insertion, which is 
unmethylated since it was synthesized in vitro. Overnight digestion in DpnI 
restricts only the methylated DNA, leaving only the mutated plasmid to be transformed into E. coli and amplified. B; Thermal 
cycle diagram of “sdm phusion” cycle used for Site-Directed Mutagenesis. The cycle begins with a 60 second denaturation phase 
B 
A 
+Phusion DNA polymerase 
SDM Phusion thermal cycling 
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at 95°C, followed by a cycle of 50 second denaturation phase at 95°C, 50 second annealing phase at 65°C, and 180 second 
extension phase at 72°C. This 3-part cycle repeats itself 18 times, followed by an additional 300 second extension phase at 72°C, 
after which the cycler holds at 4°C indefinitely (not shown). 
Following the thermal cycling, the SDM products must undergo DpnI restriction digest to 
remove all methylated template DNA. Each sample must recived 1 𝜇𝐿 of DpnI, and must 
incubate overnight (for at least 8 hours) at 37°C. The digested products can then be transformed 
into TOP10 Competent E. coli cells for amplification, and the cells miniprepped to yield mutant 
plasmid. 
Overlap Extension PCR (OE-PCR) 
The second Mutagenesis technique employed was Overlap Extension Polymerase Chain 
Reaction, (OE-PCR). The technique requires 4 oligonucleotide primers; 2 mutagenic primers 
(same as those used for SDM) and additionally 2 flanking primers. Additionally, the technique 
requires 2 separate PCR reactions carried out in parallel, followed by a second round PCR 
reaction. The reacting solution is prepared in much the same way was described for SDM; the 
key variables are the primers used and the template dsDNA used. 10 pmol of each primer, 50 ng 
template plasmid, 10 𝜇L 5X reaction buffer, 1 𝜇L dNTP, and 0.5 𝜇L Phusion DNA polymerase 
are made up to a volume of 50𝜇𝐿. The thermal cycle used is that illustrated in Figure 6B. 
The first round of PCR pairs the forward flanking primer with the reverse mutagenic primer 
(Figure 6A a + b respectively) for one reaction, and the forward mutagenic primer with the 
reverse flanking primer (Figure 6A c + d respectively). These PCR reactions are independently 
carried out with the template DNA to produce two independent dsDNA products (Figure 6A AB 
and CD), which overlap with each other over the region of the mutagenic primers. The products 
must undergo gel purification and recovery to isolate the dsDNA PCR products. In the second 
round of PCR, the products for both previous PCR reactions must be included as template DNA. 
1 𝜇𝐿 of each product, in addition to both flanking primers, are included in this reacting solution. 
The remainder of the solution should be prepared in the same way as the first PCR. This second 
round of PCR should be performed in duplicate in order to ensure enough product is produced. 
 
Figure 6; A; Visual representation of OE-PCR used for insertion, derived from 
Heckman et al. [11]. The double stranded DNA at the top represents the 
template DNA, a + d are flanking primers, and c + b are mutagenic primers. 
Flanking primer a pairs with mutagenic b, which are used together in the 
first round PCR reaction to make double stranded DNA fragment AB. Likewise, c + d pair to make CD. For the second round PCR 
reaction, dsDNA fragments AB and CD are combined along with flanking primers a + d. Denatured AB ssDNA anneals to the 
complementary CD region containing the insertion, and the fragments are extended to produce the final product of AD with the 
A 
B 
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insertion. B; Thermal cycle diagram of “pcr ykc” cycle used for both steps of Overlap-Extension PCR. The cycle begins with a 5 
minute denaturation phase at 95°C, followed by a cycle of 30 second denaturation phase at 95°C, 30 second annealing phase at 
55°C, and 45 second extension phase at 72°C. This 3-part cycle repeats itself 30 times, followed by an additional 300 second 
extension phase at 72°C, after which the cycler holds at 4°C indefinitely (not shown) 
Following gel purification of the second round PCR products, the double stranded DNA can be 
sequenced, ligated into a backbone, and expressed. 
 
Heat-Shock Plasmid Transformation into Bacteria 
For bacterial amplification of plasmids, Invitrogen TOP10 E. coli competent cells were used. 
The cells were first removed from the -80°C freezer and allowed to thaw on ice. 4 𝜇𝐿 
𝛽mercaptoethanol were added per 100 𝜇𝐿 cells in order to increase transformation efficiency by 
degrading cell surface hydrocarbons [12]. The cells were allowed to incubate for 10 more 
minutes on ice. For each transformation, 20 𝜇𝐿 of cells were added to 2 𝜇𝐿 of DpnI digested 
plasmid product in chilled microfuge tubes, which were then gently mixed and incubated on ice 
for 30 minutes. For the actual heat shock, the tubes were submerged in a 42°C water bath for 30 
seconds and then placed back on ice for 2 minutes. In a BioSafety cabinet, 300 𝜇𝐿 37°C 
preheated SOC media were added to each tube, which were then incubated in a shaker at 37°C 
for 40 minutes. Again in the Biosafety cabinet, 150 𝜇𝐿 of each tube were added to a tube 
containing 3-5 mL LB media with antibiotics (depending upon plasmid; ampicillin for pCT, 
kanamycin for pN3). This ensures that only transformed cells can grow. These tubes were then 
shaken and incubated overnight at 37°C. The following day, 20 𝜇𝐿 were plated under the 
Biosafety hood on LB with the same antibiotic as before, and incubated upside down overnight. 
More than 100 colonies are expected from this procedure, and less than 5 constitutes cause for 
concern. Colonies were picked and miniprepped to yield amplified primers. 
 
Yeast Growth and Induction for Surface Display 
Successfully transformed surface display yeast (EBY100) with pCT302 was inoculated in the 
Biosafety Cabinet into 3-5 mL SD-CAA media (a synthetic, minimal medium with glucose as a 
carbon source, casamino acids, and deficient in both tryptophan and uracil). TRP1 acts as the 
selection marker, since tryptophan synthetase allows growth on a tryptophan-deficient marker. 
This inoculated sample was incubated for 24 hours at 30°C (no more than 72 hours). (The cell 
density should be between 107 and 108 
𝑐𝑒𝑙𝑙𝑠
𝑚𝐿
 after growth, corresponding to an optical density of 
around 𝑂𝐷600 ~ 1 𝑡𝑜 10.) These cells were centrifuged and he supernatant discarded. The grown 
cells, now ready for induction, were diluted with SG-CAA to an optical density of 𝑂𝐷600 ~ 1 
and resuspended. SG-CAA media is identical to SD-CAA, except galactose replaces glucose as 
the carbon source. These samples was incubated at 20°C for at least 20 hours, but no more than 
48. After a brief diauxic shift, the GAL operon will become active, and the GAL 1-10 promoter 
on the pCT302 present will be transcribed. Being that yeast are eukaryotes capable of post-
transcriptional control of gene expression, the genes present in pCT are transcribed and 
translated to produce a hybrid protein of mutant mCherry and aga2. At the same time, the GAL-
linked AGA1 gene in the yeast DNA is also expressed. The aga1 complexes via disulfide bonds 
with the aga2-mCherry complex, which then embeds in the cell wall of the cells, and can be 
detected and measured.  
  
Kinard 10 
 
Results 
Insertion Site Identification 
Drawing from Pavoor et al., successful insertion mutations can be made between residues 
interconnecting the 𝛽-pleated sheets comprising the barrel-structure [13]. The two insertion sites 
utilized in Pavoor et al. are present at Asp-102/Asp-103 and at Glu-172/Asp-173, as illustrated in 
Figure 5B, and it has been demonstrated that GFP can retain its fluorescence when insertions of 
various lengths can be made here. 
While GFP and mCherry have notably different amino acid sequences (refer to Figure 5A), their 
barrel-and-core structures are very similar (refer to Figure 5B and 5C).  
The crystal structure of mCherry was analyzed in PyMol, and new insertion sites were sought 
between residues that: 
a) Connect β-pleated sheets comprising the barrel-structure with each other as well as the 
interconnecting the 𝛼-helices comprising the fluorescent core, as all of these sites occur 
on the edges of the barrel structure similarly to those employed in Pavoor et al., and 
b) Are not themselves a part of any secondary structure, so as not to disturb fluorescence or 
overall structure irreparably. 
 
 
Figure 7; A; an amino acid sequence alignment of GFP to mCherry performed with EBI’s webPRANK, B; Visual map of secondary 
structure for Green Fluorescent Protein annotated with residue numbers at identifying points in secondary structure [14] and 
Pavoor et al. insertion sites at Asp-102/Asp-103 and at Glu-172/Asp-173 indicated with an ‘@’ and a '#’, respectively, C; Visual 
map of secondary structure for mCherry Protein annotated with numbered and labeled (plain black text) residues at identifying 
points in secondary structure  as well as with the numbered (in black circles) and labeled (red text) original sixteen insertion sites. 
C 
A mCherry GFP 
B 
#             @ 
Kinard 11 
 
The destruction of a beta-pleated-sheet would make proper tertiary conformation impossible, and 
that of an alpha helix could fundamentally alter or destroy fluorescence. Sixteen such sites were 
identified. They are indicated in Figure 5C, as well as tabulated in Table 1. For shorthand, each 
of the 16 sites was called MC??, wherein ?? was the 2-digit form of the insertion site number.  
 
Table 1; Insertion sites MC01-MC16 paired with their positions, derived from the map in Figure 6 
Insertion Site 
MC01 Y53/E53 
MC02 K65/G66 
MC03 E104/G105 
MC04 D116/G117 
MC05 D130/G131 
MC06 S146/D147 
MC07 D147/G148 
MC08 G149/P149 
MC09 K153/K154 
MC10 E168/D169 
MC11 D184/G185 
MC12 A198/K199 
MC13 K199/K200 
MC14 Q203/L204 
MC15 N220/E221 
MC16 E221/D222 
 
 
Figure 8; a hand-annotated map of amino acid sequence for the mCherry amino acid sequence translated from the gene in pCT 
from Geneious.  Annotated with insertions sites (shaded arrow and vertical line), 𝛽-sheet (horizontal bracket and S#), and 𝛼-
helix (horizontal bracket and 𝛼#) locations 
Having identified the desired insertion sites for the TEV Protease recognition sequence, work in 
the nucleic acid domain could now begin. It is interesting and worth noting that Pavoor et al. 
insertion sites Asp-102/Asp-103 and at Glu-172/Asp-173 are roughly analogous to mCherry 
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insertion sites MC04 and MC11 respectively, with respect to the secondary and tertiary structure 
of the protein. 
 
Primer Design 
All primer design activity took place in Geneious. The TEV-PRS, having an amino acid 
sequence 7 residues in length, was coded for by a nucleic acid sequence 21 base pairs long.  
Site-Directed Mutagenesis was selected as the first method to insert the sequence into the yo-
mCherry gene. This method requires a pair of complementary primers, comprised of a segment 
of the sequence immediately upstream of the insertion site, the site itself, and a segment 
immediately downstream of the insertion site. 
 
 
Figure 9; Amino acid (bottom) sequence for the TEV-PRS to be inserted into the mCherry protein, as well as the amino acid 
sequence that codes for it. 
In generating the forward primers, 20 bp upstream of the insertion site, followed by the insertion, 
followed by 20 bp downstream were initially entered into Geneious. Since these primers will at 
no point be themselves translated, there is no need to maintain the codon reading frame, so any 
number of nucleotides can be present for the upstream and downstream binding regions. The 
lengths of these upstream and downstream binding regions were varied in order to achieve the 
desired predicted Tm value (melting temperature) of 55°C, such that it would function optimally 
with the thermal cycle employed in the first mutagenesis approach; Site-Directed Mutagenesis. 
Other factors taken into consideration when designing the primers were minimizing ΔG and 
avoiding hairpin structures that could prevent annealing of primers to template DNA, which arise 
from complementary ends. Oligonucleotide primers were all ordered from Integrated DNA 
Technologies.  
 
Figure 10; Forward (left) and Reverse (right) primers for MC03 in predicted thermostable conformation in Geneious; while there 
is a significant intrabonding occurring, the oligonucleotide conformation represented here have free ends, and can thus function 
as primers 
The first four pairs primers ordered were the forward and reverse primers for insertion sites MC-
[02,06,09,11].  
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Table 2; Forward and Reverse Primer Sequences for MC01-MC16 wherein the direction of the primer is indicated by the prefix F 
or R in front of the insertion site name 
F MC01 GAAGGTGAAGGTAGACCATACGAAAATTTGTATTTTCAAGGTGAAGGTACCCAAACCGC 25 nm 
R MC01 GCGGTTTGGGTACCTTCACCTTGAAAATACAAATTTTCGTATGGTCTACCTTCACCTTC 25 nm 
F MC02 GCTAAGTTGAAGGTCACCAAGGAAAATTTGTATTTTCAAGGTGGTGGTCCATTGCCATT 25 nm 
R MC02 AATGGCAATGGACCACCACCTTGAAAATACAAATTTTCCTTGGTGACCTTCAACTTAGC 25 nm 
F MC03 TTGAAGTTGTCTTTCCCAGAAGAAAATTTGTATTTTCAAGGTGGTTTCAAGTGGGAAAGAGT 25 nm 
R MC03 ACTCTTTCCCACTTGAAACCACCTTGAAAATACAAATTTTCTTCTGGGAAAGACAACTTCAA 25 nm 
F MC04 AAGAGTCATGAACTTCGAAGATGAAAATTTGTATTTTCAAGGTGGTGGTGTCGTCACC 25 nm 
R MC04 GGTGACGACACCACCACCTTGAAAATACAAATTTTCATCTTCGAAGTTCATGACTCTT 25 nm 
F MC05 CCAAGATTCTTCTTTGCAAGATGAAAATTTGTATTTTCAAGGTGGTGAATTCATTTACAAGGTCAA 25 nm 
R MC05 TTGACCTTGTAAATGAATTCACCACCTTGAAAATACAAATTTTCATCTTGCAAAGAAGAATCTTGG 25 nm 
F MC06 AGGTACCAACTTCCCATCTGAAAATTTGTATTTTCAAGGTGATGGTCCAGTCATGCAAA   25 nm 
R MC06 TTTGCATGACTGGACCATCACCTTGAAAATACAAATTTTCAGATGGGAAGTTGGTACCT 25 nm 
F MC07 GTACCAACTTCCCATCTGATGAAAATTTGTATTTTCAAGGTGGTCCAGTCATGCAAAAGA 25 nm 
R MC07 TCTTTTGCATGACTGGACCACCTTGAAAATACAAATTTTCATCAGATGGGAAGTTGGTAC 25 nm 
F MC08 CAACTTCCCATCTGATGGTGAAAATTTGTATTTTCAAGGTCCAGTCATGCAAAAGAAGAC 25 nm 
R MC08 GTCTTCTTTTGCATGACTGGACCTTGAAAATACAAATTTTCACCATCAGATGGGAAGTTG 25 nm 
F MC09 TGGTCCAGTCATGCAAAAGGAAAATTTGTATTTTCAAGGTAAGACCATGGGTTGGGAA 25 nm 
R MC09 TTCCCAACCCATGGTCTTACCTTGAAAATACAAATTTTCCTTTTGCATGACTGGACCA 25 nm 
F MC10 TTCTGAAAGAATGTACCCAGAAGAAAATTTGTATTTTCAAGGTGATGGTGCTTTGAAGGGT 25 nm 
R MC10 ACCCTTCAAAGCACCATCACCTTGAAAATACAAATTTTCTTCTGGGTACATTCTTTCAGAA 25 nm 
F MC11 GCAAAGATTGAAGTTGAAGGATGAAAATTTGTATTTTCAAGGTGGTGGTCACTACGATGC 25 nm 
R MC11 GCATCGTAGTGACCACCACCTTGAAAATACAAATTTTCATCCTTCAACTTCAATCTTTGC 25 nm 
F MC12 AAGACCACCTACAAGGCTGAAAATTTGTATTTTCAAGGTAAGAAGCCAGTCCAATTGC 25 nm 
R MC12 GCAATTGGACTGGCTTCTTACCTTGAAAATACAAATTTTCAGCCTTGTAGGTGGTCTT 25 nm 
F MC13 GACCACCTACAAGGCTAAGGAAAATTTGTATTTTCAAGGTAAGCCAGTCCAATTGCC 25 nm 
R MC13 GGCAATTGGACTGGCTTACCTTGAAAATACAAATTTTCCTTAGCCTTGTAGGTGGTC 25 nm 
F MC14 GCTAAGAAGCCAGTCCAAGAAAATTTGTATTTTCAAGGTTTGCCAGGTGCTTACAAC 25 nm 
R MC14 GTTGTAAGCACCTGGCAAACCTTGAAAATACAAATTTTCTTGGACTGGCTTCTTAGC 25 nm 
F MC15 AGTTGGATATTACCTCTCACAACGAAAATTTGTATTTTCAAGGTGAAGATTACACCATTGTCGAAC 25 nm 
R MC15 GTTCGACAATGGTGTAATCTTCACCTTGAAAATACAAATTTTCGTTGTGAGAGGTAATATCCAACT 25 nm 
F MC16 GGATATTACCTCTCACAACGAAGAAAATTTGTATTTTCAAGGTGAAGATTACACCATTGTCGAAC 25 nm 
R MC16 GTTCGACAATGGTGTAATCTTCACCTTGAAAATACAAATTTTCTTCGTTGTGAGAGGTAATATCC 25nm 
 
 
Mutation 
Site Directed Mutagenesis (SDM) 
The first mutation technique attempted was Site-Directed Mutagenesis (SDM) [15] [16]. This 
particular version of the process of mutation began with the yeast-optimized mCherry gene 
present in a pCT302 backbone. SDM using Phusion is more effective and less error-prone [17] 
on smaller plasmids, so transfer of the yeast-optimized mCherry gene from pCT (7 kb) to pN3 
(4.5 kb) needed to be performed. Restriction digest was performed upon pCT containing yo-
mCherry using high-fidelity forms of NheI and BsrGI. The gene was isolated using gel 
purification to separate the yo-mCherry gene/insert from the pCT backbone. The same restriction 
sites are present in pN3, so the same was done with pN3 to separate and purify the backbone. 
The isolated yo-mCherry gene was ligated into the pN3 backbone using T4 DNA Ligase. 
 
The SDM was performed on the entire pN3 plasmid containing the yo-mCherry gene, and 
yielded the same plasmid with an added mutation. The primers used contain the sequence to be 
inserted, in this case the recognition site for TEV Protease, bracketed on either side by a 
sequence complimentary to the template DNA upstream and downstream of the insertion site. 
This primer and a complementary primer (referred to as Forward and Reverse primers) are used 
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together. The complementary DNA bracketing the insertion allows for hybridization with the 
template DNA. Phusion DNA Polymerase is then used to extend the plasmid along the entire 
length of the template DNA. This is accomplished on both the forward and reverse strands, 
yielding complementary strands which are broken in different places. The template DNA can be 
eliminated by digestion using a DpnI, restriction enzyme which specifically targets methylated 
DNA, so only DNA produced in vivo is affected. This distinguishes the template from the 
mutated DNA because the template was originally produced in E. coli, and will be methylated, 
while the newly synthesized DNA will not be. [18] This can be easily amplified in E. coli cells, 
wherein cloning of the plasmid will result in uncut circular dsDNA.  
SDM was attempted using the primers ordered for insertion sites MC-[02,06,09,11]. The 
products were treated with DpnI and heat-shock transformed into TOP10 competent E. coli cells. 
These cells were plated on LB-Kanamycin. Since pN3 carries kanamycin resistance, colonies 
formed were assumed to carry the mutant plasmid. Two colonies were picked from each plate, 
incubated in liquid LB media, and the resulting cells miniprepped. The resulting plasmid DNA 
was sequenced at the UCONN Bioinformatics lab using Sanger sequencing. The results were 
analyzed in Geneious software. 
The attempt at site MC06 failed, as unwanted mutations were found. That at site MC02 was lost 
due to low concentration of DNA. Sequencing of the mutated gene after attempting to insert at 
MC09 and MC11 showed the SDM to have successfully inserted the TEV-PRS. 
 
 
Figure 11; Visualization of Sanger sequencing results analyzed in Geneious software for attempted insertions at sites MC09 (top) 
and MC11 (bottom) using Site-Directed Mutagenesis. Visual is zoomed to the insertion region. 
Eight residues downstream, so instead of inserting at MC09 (K153/K154), the insertion was 
made at (S161/S162). This insertion site will be referred to as MC0X. 
Due to the high failure rate of the attempted insertion mutations made using SDM, combined 
with the difficulty of involving another plasmid (pN3), a different mutagenesis method was 
chosen; OE-PCR. 
 
Overlap Extension PCR (OE-PCR) 
The second mutation method attempted was Overlap-Extension PCR (OE-PCR) [11]. This 
method is significantly more laborious and resource-intensive, but more reliable, and can be 
performed successfully on genes in plasmids of greater size. The end product in this case is 
linear double stranded DNA, the limits of which are determined by the primers used. The same 
primers used in SDM can be used here, in conjunction with 2 more primers which flank the gene 
of interest on either side.  
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First, two PCR reactions are performed in parallel. Each consists of one of the SDM primers, and 
one of the bracketing, or “sequencing”, primers. The “pcr ykc” thermal cycle is carried out upon 
the template DNA along with DNA Polymerase and one of the two pairs of two plasmids, 
resulting in the exponential amplification of the sequence including and between each pair of 
primers. In this case, the forward sequencing primer for the pCT plasmid containing yeast 
optimized mCherry (yo-mCherry) was paired with the reverse primer for a specific insertion site, 
and the reverse sequencing primer with the forward primer for the insertion site. This produced 2 
overlapping strands of DNA, which were complimentary only at the sites complimentary to the 
insertion site primers. Combining these overlapping DNA segments with DNA Polymerase and 
the forward and reverse sequencing primers in a “pcr ykc” thermal cycle results in the 
amplification of the entire double stranded region between the sequencing primers, including the 
mutation. The segment of DNA between the sequencing primer sites contained the protease 
recognitions sites for NheI and BSRGI, and was therefore suitable for ligation back into pCT.   
 
OE-PCR was attempted at sites MC-[01,03,04,05,06,07,12,13,14]. Beginning with pCT-yo-
mCherry, the first round of PCR was performed by pairing the forward pCT insert sequencing 
primer with the reverse mutagenic MC## primer, and the reverse pCT insert sequencing primer 
with the forward mutagenic MC## primer. The products of these respective PCR reactions were 
gel purified and recovered. The second round PCR was then conducted in duplicate, using the 
products of both first round PCR’s as well as the forward and reverse pCT insert sequencing 
primers. The resulting dsDNA was gel purified, recovered, and sequenced.  
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Sequencing reveals insertions at sites MC-[01,04,07,12,14] to have been successful without 
complication in either mutation or sequencing. 
 
 
 
Figure 12; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for 
attempted insertions at sites (from top to bottom) MC-[01,04 ,07,12,14] using OE-PCR. Visuals are zoomed to the insertion 
region. Note that in the cases of MC-[04,05,07,12], the alignmentof the last nuclotide before the insertion, a thymine, is 
misaligned to the last nucleotide of the insertion (also a thymine). This is only a software error, and does not reflect any 
problems with the sequencing.  
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Figure 13; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for 
attempted insertions at site MC06 using OE-PCR. A; The insertion site where a frameshift mutation appears to have occurred in 
the mutated sequence. B; the site of the apparent frameshift mutation. The presence of an extended, amorphous guanine peak 
indicates a sequencing assembly error. C; the site of the apparent frameshift mutation after the added guanine residue is 
manually removed. D; The insertion site where the apparent frameshift mutation has been repaired through manual deletion of 
the added guanine. (Note that in the cases of the MC06, the alignmentof the last nuclotide before the insertion, a thymine, is 
misaligned to the last nucleotide of the insertion (also a thymine). This is only a software error, and does not reflect any 
problems with the sequencing.) 
 
Figure 14; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for 
attempted insertions at site MC03  using OE-PCR. Top; TEV-PRS Insertion site, and proximal location of an apparent unwanted 
insertion mutation has occurred, resulting in a frameshift mutation. Bottom; The same site following manual deletion of the 
unwanted 1bp insertion mutation, revealing an otherwise successful MC03 insertion. 
A 
B 
C 
D 
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Figure 15;   Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for 
attempted insertions at site MC05  using OE-PCR. While the mutation region itself (top) confirms a successful OE-PCR insertion, 
downstream on the gene, the results for region between residues I212 and T217 (inclusive) is extremely noisy. Based on the 
results, expected residue I216 was predicted by Geneious to be S216 because the second base in the codon was interpreted to be 
a guanine instead of a thymine. This base was the last one in a buildup of noise, and significant peaks were present for both 
thymine and guanine. This was likely a sequencing error due to contamination or presence of an air bubble. 
 
 
Figure 16; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the yo-mCherry gene for 
attempted insertions at site MC13 using OE-PCR. While the mutation itself (top) confirms a successful OE-PCR insertion, just 
upstream of the insertion, a 2bp deletion mutation appears to have occurred. Additionally, upstream of the mutation, Geneious 
has predicted a thymine based upon sequencing results instead of the expected cytosine. There are peaks indicating both, and 
the base is flanked by two thymines on either side, so it is likely due to noise. 
 
  
Kinard 19 
 
Expression 
The successfully mutated plasmids needed to be expressed in surface display yeast to see if the 
mutant mCherry protein demonstrated fluorescence. The gene had been successfully inserted into 
pCT302, in which tryptophan synthase were also present. The purified plasmid was transformed 
into yeast EBY100 surface display yeast using METHOD. Transformed yeast was incubated in 
SD-CAA media which is deficient in Tryptophan to select for successfully transformed cells. 
These cells were centrifuged to their media were switched to SG-CAA, which is identical except 
that it replaces glucose with galactose as a carbon source. The EBY100 yeast contains the GAL 
operon, as well as an inserted GAL-regulated AGA1 surface display anchor protein. The 
introduction of galactose induces the expression of this gene, as well as the expression of the 
GAL-linked aga2-mCherry complex in pCT. As the cells are incubated in the SG-CAA medium, 
the aga1 and aga2-mCherry complex are expressed, bond, and embed in the cell wall for surface 
display. These cells are imaged under a digital microscope and transferred to a computer where 
the fluorescence in the resulting images can be quantified and compared to a control. 
 
 
 
Figure 17; Fluorescence imaging and analysis; A: fluorescence imaging for the accidental insertion that occurred in attempting 
MC09, now known as MC0X; B: fluorescence imaging from MC11; C: fluorescence imaging from the wild type yo-mCherry; D: 
digitally analyzed version of image 8.C, wherein a fluorescent expression  value was determined for each cell. 
  
D 
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Table 3; Results of fluorescence imaging and digital analysis, wherein samples 9A correspond to site MC0X 
Sample  Colony 
Count  
Average  Standard 
Deviation 
9A-1  72  209.331  60.265  
9A-2  100  220.761  60.335  
9A  (avg)  215.046   
11A-1  180  526.183  285.981  
11A-2  156  467.523  245.713  
11A  (avg)  496.853   
yoCh1  190  501.775  304.005  
yoCH2  85  606.896  339.688  
yoCh (avg)  554.3355    
 
 
Figure 18; Graphical representation of the average fluorescence units per colony for the expressed yo-mCherry mutants and the 
control on 2 individual plates as well as the average for said plates. 
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Discussion 
Mutation 
Table 4; Mutation status for each site, wherein the numbers following “MC…” refer to the sites identified in Figure 7C 
Insertion Status 
MC01 Successful mutation with OE-PCR 
MC02 Progress lost before sequencing could be performed successfully 
MC03 Possible Successful mutation with OE-PCR; Resequencing needed (see Figure 14) 
MC04 Successful mutation with OE-PCR 
MC05 Possible Successful mutation with OE-PCR; Resequencing needed (see Figure 15) 
MC06 Possible Successful mutation with OE-PCR; Resequencing needed (see Figure 13) 
MC07 Successful mutation with OE-PCR 
MC08 Not attempted 
MC09 Not attempted1 
MC10 Not attempted 
MC11 Successful mutation with SDM 
MC12 Successful mutation with OE-PCR 
MC13 Apparent failed mutation with OE-PCR; Resequencing needed (see Figure 16) 
MC14 Successful mutation with OE-PCR 
MC15 Not attempted 
MC16 Not attempted 
MC0X Successful mutation with SDM 
 
Figure 19; Visual map of mCherry structure annotated with the current status of each 
                                                 
1 Sequencing revealed insertion to have been made at an incorrect site denoted with a “?” in 
Figure 19. The accidental insertion site was made due to a clerical error in primer design, and is 
present between two pleated sheets on the side of the cylindrical structure. This site is to be 
referred to as MC0X.  
Kinard 22 
 
 
The mutations attempted were sequenced to find varying results. Site Directed Mutagenesis has 
yielded 2 confirmed successes and one confirmed failure. OE-PCR, however, has produced at 
least 5 confirmed successful mutations, likely as many as 8, and one apparent failure. Both 
methods, SDM and OE-PCR, have proven viable mutagenesis techniques. However, failures 
have been encountered in both cases. The failures may have occurred due to several causes. 
Occurrence of other mutations may be due to sequencing failure or due to the inherent likelihood 
of mutation during transcription at the low concentrations present during the beginning stages of 
thermal cycling. The actual presence of mutations can only be determined by resequencing.  
 
Based upon the outcome of the experimentation described in this report, SDM has at best a much 
higher error rate than OE-PCR. This is due to the much larger amount of genetic data processed 
during the extension phase; while OE-PCR only requires the extension of a primer to an end 
point within the gene, in this case not more than 1kb, SDM requires the primers to be extended 
around entire plasmid each cycle, over 4 kb. 
 
With regard to procedure, both methods have significant advantages and disadvantages. SDM, in 
theory, does not require a ligation step; the entire mutation can be achieved through thermal 
cycling followed by amplification in bacteria and miniprep. In the case of this experiment, 
however, this advantage did not apply, due to constraints later on in the experiment. Both pCT 
and pN3 were needed, as the gene was initially present in pCT, and needed to be returned to pCT 
for expression in yeast, but SDM could not be performed directly on pCT due to its size. This 
added the double digest and ligation steps both before and after SDM was performed. pCT, on 
the other hand, is as labor intensive both in theory as in practice. The technique requires two 
independent PCR steps, each followed by gel purification and recovery, and finally double digest 
and ligation back into the pCT backbone. 
 
Due to the significantly lower error rate and the similar amount of work required for both 
techniques under these circumstances, OE-PCR is the preferred technique for the insertion of the 
TEV-PRS into the to-mCherry gene followed by yeast surface display. 
 
The insertion at site MC0X occurred due to a clerical error when designing primers. While not 
originally identified as a potential insertion site, the site satisfies some of the conditions laid out 
in the Theory section of this report, in that it does not disturb secondary structure. While it is not 
present in a loop connecting slats or helical core of the barrel-structure, it does connect two beta-
sheets which make up a single slat, disrupting tertiary structure, but not secondary. 
Structurally, this mutation is very intriguing, as the conformation may be analogous to a broken 
slat in the barrel structure being propped outward, slightly warping the entire structure. The site 
appears plausible for further investigation. 
 
Expression 
The fluorescence results are the only quantitative results from the entire body of lab work.  
The sought after mutant, as described in the Theory section, would exhibit minimal or no 
fluorescence before cleavage, and significant fluorescence after cleavage. Of the two sites 
expressed, MC11 and MC0X, both exhibited fluorescence. MC11 displayed nearly fluorescence 
that was not statistically different from the wild-type, indicating that this insertion site is not 
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suitable for use as an in vivo protease sensor, as cleavage would at best result in a minor increase 
in fluorescence. The second site, MC0X, presented with a substantial reduction in fluorescence, 
of greater than 50%. While this is not as great a reduction as desired, it is currently the closest to 
the sought after mutant.  
Conclusion 
It is difficult to draw conclusions from an incomplete research project. Being that this thesis 
functions more as a progress report than a conclusive research paper, most of the take-away 
pertains to future steps. Regarding the seventeen identified sites, the current state of the research 
project is as follows: 
 
• Neither of the two successfully expressed mutations exhibited the desired lack of 
fluorescence. One, however, which was not initially desired, exhibited a reduction in 
fluorescence of greater than 50%. 
• At least five additional insertions have been successfully made and confirmed with 
sequencing, with an additional three that require resequencing to confirm sequencing 
error, and these are ready for expression in yeast. 
• Progress on two insertion sites attempted has been lost due to procedural error. Primers 
for MC09 should be redesigned to target the intended site, and insertion MC02 should be 
attempted again using OE-PCR. 
• Primers for the remaining four identified insertion sites have not been ordered, in 
addition to one redesigned pair of primers for site MC09. 
  
In summary, moving forward, all successfully mutated sequences should be expressed in yeast. 
The remaining insertion sites should be attempted using OEPCR, as this technique requires 
comparable labor and is far more reliable. All successfully mutated versions of the yo-mCherry 
gene should be expressed in yeast, and then introduced to TEV protease to test for real-time in 
vivo viability as protease sensors. Finally, it may be interesting and useful to investigate the 
structure of the mutated mCherry-MC0x and others using X-Ray crystallography. 
 
The results thus far indicate that the project shows promise, since the expressed mutations thus 
far have exhibited reductions in fluorescence. Other undergraduate research assistants in Dr. 
Yongku Cho’s lab will continue pursuit of the desired mutation. Research on the project thus far 
was performed under instruction of Dr. Cho by undergraduates Kathryn Frances, Krystyna 
Kapalczynski, Hamze Mah, Caroline Olesiak, Steven Rodriguez, Moe Uddin, and myself. Work 
will be carried forward by Hamze Mah, Kathryn Frances, and others in the lab, as all others once 
assigned to the project have since graduated. 
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Figure 1; Visualization of the mCherry secondary and tertiary structure generated in PyMOL with an 
Educational License, with the color gradient from N to C terminus. .................................................... 3 
Figure 2; Visual map of mCherry structure wherein arrows represent β-pleated sheets and cylinders 
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Figure 4; Plasmid maps of pCT302 (left) and pN3 (right) from addgene ...................................................... 6 
Figure 5; A; Visual representation of Site-Directed Mutagenesis used for insertion, derived from Geiser 
et al. [10]. The segmented loop represents the template plasmid (which is methylated, as it was 
synthesized in vivo), while the thick black segment represents the insertion. The primers are 
extended from the 3’ end along the template DNA until termination at their own 5’ end, resulting in 
a complete, nicked plasmid with the insertion, which is unmethylated since it was synthesized in 
vitro. Overnight digestion in DpnI restricts only the methylated DNA, leaving only the mutated 
plasmid to be transformed into E. coli and amplified. B; Thermal cycle diagram of “sdm phusion” 
cycle used for Site-Directed Mutagenesis. The cycle begins with a 60 second denaturation phase at 
95°C, followed by a cycle of 50 second denaturation phase at 95°C, 50 second annealing phase at 
65°C, and 180 second extension phase at 72°C. This 3-part cycle repeats itself 18 times, followed by 
an additional 300 second extension phase at 72°C, after which the cycler holds at 4°C indefinitely 
(not shown). ........................................................................................................................................... 7 
Figure 6; A; Visual representation of OE-PCR used for insertion, derived from Heckman et al. [11]. The 
double stranded DNA at the top represents the template DNA, a + d are flanking primers, and c + b 
are mutagenic primers. Flanking primer a pairs with mutagenic b, which are used together in the 
first round PCR reaction to make double stranded DNA fragment AB. Likewise, c + d pair to make 
CD. For the second round PCR reaction, dsDNA fragments AB and CD are combined along with 
flanking primers a + d. Denatured AB ssDNA anneals to the complementary CD region containing 
the insertion, and the fragments are extended to produce the final product of AD with the insertion. 
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B; Thermal cycle diagram of “pcr ykc” cycle used for both steps of Overlap-Extension PCR. The cycle 
begins with a 5 minute denaturation phase at 95°C, followed by a cycle of 30 second denaturation 
phase at 95°C, 30 second annealing phase at 55°C, and 45 second extension phase at 72°C. This 3-
part cycle repeats itself 30 times, followed by an additional 300 second extension phase at 72°C, 
after which the cycler holds at 4°C indefinitely (not shown) ................................................................ 8 
Figure 7; A; an amino acid sequence alignment of GFP to mCherry performed with EBI’s webPRANK, B; 
Visual map of secondary structure for Green Fluorescent Protein annotated with residue numbers 
at identifying points in secondary structure [14] and Pavoor et al. insertion sites at Asp-102/Asp-
103 and at Glu-172/Asp-173 indicated with an ‘@’ and a '#’, respectively, C; Visual map of 
secondary structure for mCherry Protein annotated with numbered and labeled (plain black text) 
residues at identifying points in secondary structure  as well as with the numbered (in black circles) 
and labeled (red text) original sixteen insertion sites. ........................................................................ 10 
Figure 8; a hand-annotated map of amino acid sequence for the mCherry amino acid sequence 
translated from the gene in pCT from Geneious.  Annotated with insertions sites (shaded arrow and 
vertical line), β-sheet (horizontal bracket and S#), and α-helix (horizontal bracket and α#) locations
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Figure 9; Amino acid (bottom) sequence for the TEV-PRS to be inserted into the mCherry protein, as well 
as the amino acid sequence that codes for it. ..................................................................................... 12 
Figure 10; Forward (left) and Reverse (right) primers for MC03 in predicted thermostable conformation 
in Geneious; while there is a significant intrabonding occurring, the oligonucleotide conformation 
represented here have free ends, and can thus function as primers ................................................. 12 
Figure 11; Visualization of Sanger sequencing results analyzed in Geneious software for attempted 
insertions at sites MC09 (top) and MC11 (bottom) using Site-Directed Mutagenesis. Visual is 
zoomed to the insertion region. .......................................................................................................... 14 
Figure 12; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the 
yo-mCherry gene for attempted insertions at sites (from top to bottom) MC-[01,04 ,07,12,14] using 
OE-PCR. Visuals are zoomed to the insertion region. Note that in the cases of MC-[04,05,07,12], the 
alignmentof the last nuclotide before the insertion, a thymine, is misaligned to the last nucleotide 
of the insertion (also a thymine). This is only a software error, and does not reflect any problems 
with the sequencing. ........................................................................................................................... 16 
Figure 13; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the 
yo-mCherry gene for attempted insertions at site MC06 using OE-PCR. A; The insertion site where a 
frameshift mutation appears to have occurred in the mutated sequence. B; the site of the apparent 
frameshift mutation. The presence of an extended, amorphous guanine peak indicates a 
sequencing assembly error. C; the site of the apparent frameshift mutation after the added guanine 
residue is manually removed. D; The insertion site where the apparent frameshift mutation has 
been repaired through manual deletion of the added guanine. (Note that in the cases of the MC06, 
the alignmentof the last nuclotide before the insertion, a thymine, is misaligned to the last 
nucleotide of the insertion (also a thymine). This is only a software error, and does not reflect any 
problems with the sequencing.) .......................................................................................................... 17 
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Figure 14; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the 
yo-mCherry gene for attempted insertions at site MC03  using OE-PCR. Top; TEV-PRS Insertion site, 
and proximal location of an apparent unwanted insertion mutation has occurred, resulting in a 
frameshift mutation. Bottom; The same site following manual deletion of the unwanted 1bp 
insertion mutation, revealing an otherwise successful MC03 insertion. ............................................ 17 
Figure 15;   Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the 
yo-mCherry gene for attempted insertions at site MC05  using OE-PCR. While the mutation region 
itself (top) confirms a successful OE-PCR insertion, downstream on the gene, the results for region 
between residues I212 and T217 (inclusive) is extremely noisy. Based on the results, expected 
residue I216 was predicted by Geneious to be S216 because the second base in the codon was 
interpreted to be a guanine instead of a thymine. This base was the last one in a buildup of noise, 
and significant peaks were present for both thymine and guanine. This was likely a sequencing 
error due to contamination or presence of an air bubble. ................................................................. 18 
Figure 16; Visualization of Sanger sequencing results analyzed in Geneious software and aligned to the 
yo-mCherry gene for attempted insertions at site MC13 using OE-PCR. While the mutation itself 
(top) confirms a successful OE-PCR insertion, just upstream of the insertion, a 2bp deletion 
mutation appears to have occurred. Additionally, upstream of the mutation, Geneious has 
predicted a thymine based upon sequencing results instead of the expected cytosine. There are 
peaks indicating both, and the base is flanked by two thymines on either side, so it is likely due to 
noise. .................................................................................................................................................... 18 
Figure 17; Fluorescence imaging and analysis; A: fluorescence imaging for the accidental insertion that 
occurred in attempting MC09, now known as MC0X; B: fluorescence imaging from MC11; C: 
fluorescence imaging from the wild type yo-mCherry; D: digitally analyzed version of image 8.C, 
wherein a fluorescent expression  value was determined for each cell. ............................................ 19 
Figure 18; Graphical representation of the average fluorescence units per colony for the expressed yo-
mCherry mutants and the control on 2 individual plates as well as the average for said plates. ...... 20 
Figure 19; Visual map of mCherry structure annotated with the current status of each ........................... 21 
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Nomenclature 
TEV – Tobacco Etch Virus 
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TEV-PRS - Tobacco Etch Virus Protease Recognition Site 
SDM – Site Directed Mutagenesis 
OE-PCR – Overlap Extension Polymerase Chain Reaction 
PCR – Polymerase Chain Reaction 
GFP – Green Fluorescent Protein 
RFP – Red Fluorescent Protein 
yo-mCherry – Yeast Optomized m(onomeric)Cherry 
 
 
